Related Experiment Video
Updated: Aug 18, 2026

Flow Cytometric Detection of Newly-formed Breast Cancer Stem Cell-like Cells After Apoptosis Reversal
Published on: January 26, 2019
Reversal of malignant transformation by tumor DNA
Abstract:
Walker-256 carcinosarcoma cells grown in tissue culture medium containing inhibitory DNA prepared from the tumor are shown to have an unaltered growth in vitro, but a diminished capacity to produce malignant tumors on injection into the rat. Coincident with this change in virulence is the induction of tRNA methylase inhibitors in these malignant cells. Within days after the DNA is removed from the growth medium, the tRNA methylase inhibitors disappear and the oncogenicity reappears.
Insights
Inhibitory DNA reduced tumor cell malignancy in rats by inducing tRNA methylase inhibitors. Removing the DNA restored tumor-producing capacity, highlighting DNA's role in cancer virulence.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Walker-256 carcinosarcoma is a well-characterized rat tumor model.
- Tumorigenicity is a key characteristic of malignant cells.
- DNA and its interactions can influence cellular behavior.
Purpose of the Study:
- To investigate the effect of tumor-derived inhibitory DNA on Walker-256 carcinosarcoma cell malignancy in vitro and in vivo.
- To explore the relationship between DNA treatment, cellular virulence, and the induction of specific enzyme inhibitors.
Main Methods:
- Walker-256 carcinosarcoma cells were cultured in vitro with tumor-derived inhibitory DNA.
- Cellular growth was assessed in vitro.
- Tumorigenicity was evaluated by injecting treated cells into rats.
- The presence of tRNA methylase inhibitors was measured in treated cells.
Main Results:
- In vitro growth of carcinosarcoma cells was unaffected by inhibitory DNA.
- In vivo injection of DNA-treated cells resulted in diminished tumor formation (reduced oncogenicity).
- Treatment with inhibitory DNA led to the induction of tRNA methylase inhibitors in the malignant cells.
- Removal of inhibitory DNA from the culture medium caused the disappearance of tRNA methylase inhibitors and the reappearance of oncogenicity.
Conclusions:
- Tumor-derived inhibitory DNA can reduce the malignant potential of cancer cells without affecting their in vitro growth.
- The reduction in virulence is associated with the induction of tRNA methylase inhibitors.
- This suggests a mechanism by which specific DNA fractions can modulate cancer cell oncogenicity, offering potential therapeutic insights.
Related Concept Videos
Abnormal Proliferation
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Treatment Resistant Cancers
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

